Literature DB >> 24074602

HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus.

Sharof M Tugizov1, Rossana Herrera, Peter Chin-Hong, Piri Veluppillai, Deborah Greenspan, J Michael Berry, Christopher D Pilcher, Caroline H Shiboski, Naomi Jay, Mary Rubin, Aung Chein, Joel M Palefsky.   

Abstract

The incidence of human papillomavirus (HPV)-associated epithelial lesions is substantially higher in human immunodeficiency virus (HIV)-infected individuals than in HIV-uninfected individuals. The molecular mechanisms underlying the increased risk of HPV infection in HIV-infected individuals are poorly understood. We found that HIV proteins tat and gp120 were expressed within the oral and anal mucosal epithelial microenvironment of HIV-infected individuals. Expression of HIV proteins in the mucosal epithelium was correlated with the disruption of epithelial tight junctions (TJ). Treatment of polarized oral, cervical and anal epithelial cells, and oral tissue explants with tat and gp120 led to disruption of epithelial TJ and increased HPV pseudovirion (PsV) paracellular penetration in to the epithelium. PsV entry was observed in the basal/parabasal cells, the cells in which the HPV life cycle is initiated. Our data suggest that HIV-associated TJ disruption of mucosal epithelia may potentiate HPV infection and subsequent development of HPV-associated neoplasia.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disruption of tight junctions; HIV; HPV; HPV paracellular penetration; Mucosal epithelium

Mesh:

Year:  2013        PMID: 24074602      PMCID: PMC3809142          DOI: 10.1016/j.virol.2013.08.018

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  88 in total

1.  Cationic TAT peptide transduction domain enters cells by macropinocytosis.

Authors:  Ian M Kaplan; Jehangir S Wadia; Steven F Dowdy
Journal:  J Control Release       Date:  2005-01-20       Impact factor: 9.776

2.  Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy.

Authors:  S Sonza; H P Mutimer; R Oelrichs; D Jardine; K Harvey; A Dunne; D F Purcell; C Birch; S M Crowe
Journal:  AIDS       Date:  2001-01-05       Impact factor: 4.177

3.  Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals.

Authors:  Hiroyu Hatano; Eric L Delwart; Philip J Norris; Tzong-Hae Lee; Torsten B Neilands; Colleen F Kelley; Peter W Hunt; Rebecca Hoh; Jeffrey M Linnen; Jeffrey N Martin; Michael P Busch; Steven G Deeks
Journal:  AIDS       Date:  2010-10-23       Impact factor: 4.177

4.  Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study.

Authors:  Alexandra de Pokomandy; Danielle Rouleau; George Ghattas; Sylvie Vézina; Pierre Coté; John Macleod; Guy Allaire; Eduardo L Franco; François Coutlée
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

5.  Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells.

Authors:  Shinichi Nakamuta; Hiroshi Endo; Youichiro Higashi; Aoi Kousaka; Hiroshi Yamada; Mihiro Yano; Hiroshi Kido
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

6.  Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins.

Authors:  Antonio Fittipaldi; Aldo Ferrari; Monica Zoppé; Caterina Arcangeli; Vittorio Pellegrini; Fabio Beltram; Mauro Giacca
Journal:  J Biol Chem       Date:  2003-05-27       Impact factor: 5.157

7.  In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues.

Authors:  G J Nuovo; A Forde; P MacConnell; R Fahrenwald
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

8.  Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1.

Authors:  John F Alcorn; Amy S Guala; Jos van der Velden; Brian McElhinney; Charles G Irvin; Roger J Davis; Yvonne M W Janssen-Heininger
Journal:  J Cell Sci       Date:  2008-03-11       Impact factor: 5.285

9.  Intracellular calcium release induced by human immunodeficiency virus type 1 (HIV-1) surface envelope glycoprotein in human intestinal epithelial cells: a putative mechanism for HIV-1 enteropathy.

Authors:  G Dayanithi; N Yahi; S Baghdiguian; J Fantini
Journal:  Cell Calcium       Date:  1995-07       Impact factor: 6.817

10.  Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan.

Authors:  Jeffrey N Roberts; Christopher B Buck; Cynthia D Thompson; Rhonda Kines; Marcelino Bernardo; Peter L Choyke; Douglas R Lowy; John T Schiller
Journal:  Nat Med       Date:  2007-07-01       Impact factor: 53.440

View more
  45 in total

Review 1.  Human papillomavirus in the HIV-infected host: epidemiology and pathogenesis in the antiretroviral era.

Authors:  Cristina Brickman; Joel M Palefsky
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

Review 2.  Cancer in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era.

Authors:  Cristina Brickman; Joel M Palefsky
Journal:  Curr HIV/AIDS Rep       Date:  2015-12       Impact factor: 5.071

3.  Comorbidities associated with HIV and antiretroviral therapy (clinical sciences): a workshop report.

Authors:  L T Vernon; Plp Jayashantha; M M Chidzonga; M C Komesu; R G Nair; N W Johnson
Journal:  Oral Dis       Date:  2016-04       Impact factor: 3.511

4.  Viral infections associated with oral cancers and diseases in the context of HIV: a workshop report.

Authors:  D J Speicher; V Ramirez-Amador; D P Dittmer; J Webster-Cyriaque; M T Goodman; A-B Moscicki
Journal:  Oral Dis       Date:  2016-04       Impact factor: 3.511

Review 5.  Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease.

Authors:  Sharof Tugizov
Journal:  Tissue Barriers       Date:  2016-03-03

Review 6.  The interaction between human papillomavirus and other viruses.

Authors:  J T Guidry; R S Scott
Journal:  Virus Res       Date:  2016-11-05       Impact factor: 3.303

7.  Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.

Authors:  Daniel C Beachler; Elizabeth A Sugar; Joseph B Margolick; Kathleen M Weber; Howard D Strickler; Dorothy J Wiley; Ross D Cranston; Robert D Burk; Howard Minkoff; Susheel Reddy; Weihong Xiao; Yingshi Guo; Maura L Gillison; Gypsyamber D'Souza
Journal:  Am J Epidemiol       Date:  2014-12-04       Impact factor: 4.897

8.  HIV Infection and Survival Among Women With Cervical Cancer.

Authors:  Scott Dryden-Peterson; Memory Bvochora-Nsingo; Gita Suneja; Jason A Efstathiou; Surbhi Grover; Sebathu Chiyapo; Doreen Ramogola-Masire; Malebogo Kebabonye-Pusoentsi; Rebecca Clayman; Abigail C Mapes; Neo Tapela; Aida Asmelash; Heluf Medhin; Akila N Viswanathan; Anthony H Russell; Lilie L Lin; Mukendi K A Kayembe; Mompati Mmalane; Thomas C Randall; Bruce Chabner; Shahin Lockman
Journal:  J Clin Oncol       Date:  2016-11-01       Impact factor: 44.544

Review 9.  Cancer prevention in HIV-infected populations.

Authors:  Priscila H Goncalves; Jairo M Montezuma-Rusca; Robert Yarchoan; Thomas S Uldrick
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

Review 10.  HIV, Aging, and Viral Coinfections: Taking the Long View.

Authors:  Tamar H Taddei; Vincent Lo Re; Amy C Justice
Journal:  Curr HIV/AIDS Rep       Date:  2016-10       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.